View in EDS

Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel.

Saved in:
Bibliographic Details
Title: Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel.
Authors: Droz JP; aDepartment of Medical Oncology, Centre Léon-Bérard, Claude Bernard Lyon-1 University, Lyon bMedical Oncology Department, Georges Pompidou European Hospital (HEGP), Paris cDepartment of Medical Oncology, Institut Claudius Regaud, Toulouse dBoehringer Ingelheim France S.A.S, Reims, France eBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Medioni J, Chevreau C, De Mont-Serrat H, Merger M, Stopfer P, Kaiser R, Oudard S
Source: Anti-cancer drugs [Anticancer Drugs] 2014 Oct; Vol. 25 (9), pp. 1081-8.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24849708
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Droz+JP%22">Droz JP</searchLink>; aDepartment of Medical Oncology, Centre Léon-Bérard, Claude Bernard Lyon-1 University, Lyon bMedical Oncology Department, Georges Pompidou European Hospital (HEGP), Paris cDepartment of Medical Oncology, Institut Claudius Regaud, Toulouse dBoehringer Ingelheim France S.A.S, Reims, France eBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.<br /><searchLink fieldCode="AU" term="%22Medioni+J%22">Medioni J</searchLink><br /><searchLink fieldCode="AU" term="%22Chevreau+C%22">Chevreau C</searchLink><br /><searchLink fieldCode="AU" term="%22De+Mont-Serrat+H%22">De Mont-Serrat H</searchLink><br /><searchLink fieldCode="AU" term="%22Merger+M%22">Merger M</searchLink><br /><searchLink fieldCode="AU" term="%22Stopfer+P%22">Stopfer P</searchLink><br /><searchLink fieldCode="AU" term="%22Kaiser+R%22">Kaiser R</searchLink><br /><searchLink fieldCode="AU" term="%22Oudard+S%22">Oudard S</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229100823%22">Anti-cancer drugs</searchLink> [Anticancer Drugs] 2014 Oct; Vol. 25 (9), pp. 1081-8.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9100823 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-5741 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209594973%22">09594973 </searchLink><i>NLM ISO Abbreviation: </i>Anticancer Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24849708
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/CAD.0000000000000131
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1081
    Titles:
      – TitleFull: Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Droz JP
      – PersonEntity:
          Name:
            NameFull: Medioni J
      – PersonEntity:
          Name:
            NameFull: Chevreau C
      – PersonEntity:
          Name:
            NameFull: De Mont-Serrat H
      – PersonEntity:
          Name:
            NameFull: Merger M
      – PersonEntity:
          Name:
            NameFull: Stopfer P
      – PersonEntity:
          Name:
            NameFull: Kaiser R
      – PersonEntity:
          Name:
            NameFull: Oudard S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2014 Oct
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1473-5741
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Anti-cancer drugs
              Type: main
ResultId 1